Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04395755|
Recruitment Status : Completed
First Posted : May 20, 2020
Last Update Posted : July 28, 2020
Infertility is a severely distressing experience for many couples. Depression and anxiety are psychological disorders associated with infertility, and they may worsen during infertility treatments.
This study times to understand the changes in the psychological status of infertile patients who had in vitro fertilization (IVF) treatment interrupted or postponed because of the COVID-19 pandemic.
|Condition or disease||Intervention/treatment|
|Infertility, Female ART IVF COVID-19||Behavioral: Generalized Anxiety Disorder-7 (GAD-7) Behavioral: Patient Health Questionnaire-9 (PHQ-9)|
|Study Type :||Observational|
|Actual Enrollment :||503 participants|
|Official Title:||Impact of COVID-19 Pandemic on the Psychological Status of Infertile Patients Who Had in Vitro Fertilization Treatment Interrupted or Postponed|
|Actual Study Start Date :||April 1, 2020|
|Actual Primary Completion Date :||May 15, 2020|
|Actual Study Completion Date :||May 15, 2020|
|Infertile women who had the IVF treatment postponed or delayed||
Behavioral: Generalized Anxiety Disorder-7 (GAD-7)
The GAD-7 is useful in primary care and mental health settings as a screening tool and symptom severity measure for the four most common anxiety disorders.
Behavioral: Patient Health Questionnaire-9 (PHQ-9)
The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression.
- Severity of anxiety [ Time Frame: 1-4 weeks after communication of interrupted or delayed IVF ]
- Severity of depression [ Time Frame: 1-4 weeks after communication of interrupted or delayed IVF ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04395755
|IRCCS Ospedale Policlinico San Martino|
|Genoa, Italy, 16132|